Russia's vaccine proves effective — Investors are betting big on specialized primary care — SWORD Health's pitch deck

Your weekly healthcare analysis.

Subscribe to Business Insider View in browser       Hello, Today in healthcare news: Russia's coronavirus vaccine is 91.6% effective, investors are increasingly betting big on more specialized primary care, and an inside look at the pitch deck SWORD Health used to raise $25 million.  Russia's coronavirus vaccine is 91.6% effective, study shows, 5 months after the country approved it and started giving it to people Russia's coronavirus vaccine is 91.6% effective, per an interim analysis of phase-3 data published in The Lancet. Russia approved the drug for emergency use in August, before phase 3 trials, and started giving it to the public in December. One expert said the study had some caveats, but that the results seem to endorse Russia's strategy. Read the full story from Sinéad Baker and Dr. Catherine Schuster-Bruce here>> A healthcare startup serving LGBTQIA+ patients just raised $25 million, and its growth reveals a key area of opportunity for other primary care startups Folx, a consumer healthcare startup for LGBTQIA+ patients, raised $25 million in Series A funding from Bessemer Venture Partners, the company said on Tuesday. The startup provides telemedicine visits for LGBTQIA+ patients in addition to mailed hormone replacement therapy for transgender patients. Primary care startups serving specific populations instead of a more generalist audience have raised more than $1 billion in the last several years, according to Pitchbook data. Read the full story from Megan Hernbroth here>> We got an exclusive look at the presentation that had investors working over the holidays to invest $25 million in the latest startup tackling remote physical therapy SWORD Health, a startup that provides remote physical therapy, raised $25 million in Series B funding from Transformation Capital and existing investors. Founder and CEO Virgilio Bento said he struggled to contain investor interest in the round, which closed on Christmas Day. We got an exclusive look at the presentation Bento used to win over his new investor and board member. Read the full story from Megan Hernbroth here>>  More stories we're reading: New York health officials are quitting as Gov. Andrew Cuomo says he doesn't trust experts (The New York Times)  Planned Parenthood's president on the big changes ahead for reproductive rights and her organization's many other asks of the Biden administration (Insider) CureVac has signed a deal with Bayer to increase vaccine distribution in Europe (Bloomberg) Oxford researchers didn't tell COVID-19 vaccine trial volunteers of a dosing mistake when it was discovered, a letter reveals (Insider) - Lydia           Was this email forwarded to you? SUBSCRIBE NOW     You received this email because you signed up to this Insider newsletter using the email: aymentanaze.news@blogger.com   Email preferences Unsubscribe TERMS OF SERVICE PRIVACY POLICY 1 Liberty Plaza, 8th Floor. New York, NY 10006